Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-27
2006-06-27
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S335000, C514S345000, C514S347000, C546S255000, C546S290000, C546S294000
Reexamination Certificate
active
07067539
ABSTRACT:
The invention relates to compounds of the formulaa prodrug thereof, or a pharmaceutically acceptable salt, solvate or stereoisomer of the compound or of said prodrug; which exhibit anti-inflammatory and immunodulatory activity. Also disclosed are pharmaceutical compositions containing said compounds and methods of using the compounds for the treatment of various diseases and conditions.
REFERENCES:
patent: 3715375 (1973-02-01), Shen et al.
patent: 4170648 (1979-10-01), Owen et al.
patent: 4466965 (1984-08-01), Stout et al.
patent: 4468389 (1984-08-01), Ollinger et al.
patent: 4567184 (1986-01-01), Musser et al.
patent: 4781866 (1988-11-01), Maryanoff et al.
patent: 5332820 (1994-07-01), Duncia et al.
patent: 5338753 (1994-08-01), Burstein et al.
patent: 5462960 (1995-10-01), Barth et al.
patent: 5486525 (1996-01-01), Summers, Jr. et al.
patent: 5532237 (1996-07-01), Gallant et al.
patent: 5747524 (1998-05-01), Cullinan et al.
patent: 5925768 (1999-07-01), Barth et al.
patent: 5948777 (1999-09-01), Bender et al.
patent: 5990170 (1999-11-01), Della Valle et al.
patent: 6013648 (2000-01-01), Rinaldi et al.
patent: 6017919 (2000-01-01), Inaba et al.
patent: 28 38 988 (1978-06-01), None
patent: 19533644 (1995-09-01), None
patent: 197 40 785 (1997-09-01), None
patent: 00/50225 (1981-09-01), None
patent: 00/65658 (1982-04-01), None
patent: 00/85028 (1983-01-01), None
patent: 0181568 (1986-05-01), None
patent: 02/19429 (1986-10-01), None
patent: 02/64019 (1987-09-01), None
patent: 02/64020 (1987-09-01), None
patent: 02/74867 (1987-12-01), None
patent: 05/60407 (1987-12-01), None
patent: 05/87193 (1990-02-01), None
patent: 0401030 (1990-12-01), None
patent: 0407217 (1991-01-01), None
patent: 04/54067 (1991-04-01), None
patent: 04/78363 (1991-09-01), None
patent: 1031571 (2000-08-01), None
patent: 1283039 (2003-02-01), None
patent: 06072979 (1994-03-01), None
patent: WO 87/05781 (1987-10-01), None
patent: WO 87/05898 (1987-10-01), None
patent: WO 93/00313 (1993-01-01), None
patent: WO 93/21158 (1993-10-01), None
patent: WO 94/05330 (1994-03-01), None
patent: WO 95/00491 (1995-01-01), None
patent: WO 95/27693 (1995-10-01), None
patent: WO 96/23783 (1996-08-01), None
patent: WO 96/41625 (1996-12-01), None
patent: WO 97/03953 (1997-02-01), None
patent: WO 98/01422 (1998-01-01), None
patent: WO 98/10763 (1998-03-01), None
patent: WO 98/31227 (1998-07-01), None
patent: WO 98/33769 (1998-08-01), None
patent: WO 98/41519 (1998-09-01), None
patent: WO 99/26612 (1999-06-01), None
patent: WO 99/36393 (1999-07-01), None
patent: WO 99/50245 (1999-10-01), None
patent: WO 00/06146 (2000-02-01), None
patent: WO 00/56707 (2000-09-01), None
patent: WO 01/19807 (2001-03-01), None
patent: WO 01/28557 (2001-04-01), None
patent: WO 01/37826 (2001-05-01), None
patent: WO 01/44172 (2001-06-01), None
patent: WO 01/44239 (2001-06-01), None
patent: WO 01/64642 (2001-09-01), None
patent: WO 01/70753 (2001-09-01), None
patent: WO 01/70753 (2001-09-01), None
patent: WO 01/74762 (2001-10-01), None
patent: WO 01/83460 (2001-11-01), None
patent: WO 02/42248 (2002-05-01), None
patent: WO 02/062750 (2002-08-01), None
patent: WO 03/042174 (2003-05-01), None
International Search Report for PCT/US 03/24398 dated Aug. 5, 2003 for AL01381K—6 Pages.
M. Curtin et al., “Discovery and Evaluation of a Series of 3-Acylindole Imidazopyridine Platelet-Activating Factor Antagonists”, 41(I)J. Med. Chem.74-95 (1998).
G. Hartman et al., “4-Substituted Thiophene—and Furan—2-sulfonamides as topical carbonic anhydrase inhibitors” 35(21)J. Med. Chem.3822-31 (1992).
G. Hartman et al., “Synthesis and derivatization of 4-(arylsulfonyl) thiophene -and—furan—2 sulfonamides”, 27(2)J. Heterocycl. Chem.127-34 (1990).
P. Cozzi et al., New N-(2-ethoxyethyl)-N-(4-phenoxybenzyl) dichloroacetamides as potent antiamebic agents 18(3)Eur. J. Med. Chem.203-208 (1983).
U.S. Appl. No. 03/024,398 (AL01381K1) for “Cannabinoid Receptor Ligands”, filed Aug. 5, 2003.
U.S. Appl. No. 10/464,174 (AL01561K) for “Cannabinoid Receptor Agonists”, filed Jun. 17, 2003.
R.G. Pertwee, “Pharmacology of Cannabinoid Receptor Ligands”, Curr. Med. Chem 6(8), (1999), 635-664.
T.W. Greene et al. Protective Groups in Organic Synthesis (1981), Wiley, New York.
T. Higuchi and V. Stella, Pro-drugs as Novel Drug Delivery Systems (1975) 14 of the A.C.S. Symposium Series.
Bio reversible Carriers in Drug Design, (1987) Edward B. Roche, ed., American Pharmaceutical Association and Pergamon Press.
S. Berge et al., “Pharmaceutical Salts”, Journal of Pharmaceutical Sciences (1977) 66(1) 1-19.
P. Gould, “Salt Selection for Basic Drugs”, International J. of Pharmaceutics (1986) 33 201-217.
Anderson et al, The Practice of Medicinal Chemistry (1996), Academic Press, New York.
Copy of International Search Report for PCT/US 03/19245 (AL01561K).
Kozlowski Joseph A.
Lavey Brian J.
Rizvi Razia K.
Shankar Bandarpalle B.
Shih Neng-Yang
Blinka Thomas
Coppins Janet L
Saeed Kamal A.
Schering Corporation
LandOfFree
Cannabinoid receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cannabinoid receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cannabinoid receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3677147